Trial of Lenvatinib Plus Pembrolizumab in Subjects With Selected Solid Tumors

Condition:   Solid Tumors
Interventions:   Drug: lenvatinib;   Drug: pembrolizumab
Sponsor:   Eisai Co., Ltd.
Not yet recruiting - verified December 2016

http://ift.tt/2iynFGf


http://ift.tt/2iqmH1B